Thank you very much, Madam Chair.
I want to thank all the committee members for inviting me here today.
I’ve worked closely with this committee over the last four and a half years, and I appreciate the excellent work you do on a range of important issues that impact Canadians and Canadian businesses.
Before I begin, I would like to recognize the efforts of all Canadians to follow the recommendations of public health officials and keep everyone safe.
This is a collective effort by all governments across the country. I've never been prouder to be part of team Canada. My thoughts are with the people who are suffering or who have lost loved ones to this pandemic. I also want to recognize the tremendous work of our front-line workers: the health care providers, the emergency responders, and the many, many Canadians who keep our homes safe and filled with food.
I also want to recognize the contributions of companies big and small, as well as those of our exceptional research community, and thank them for their ongoing work.
Let me start by addressing the restart of the economy.
We know there will be real impacts while the shutdown measures are in place, but we cannot lose sight of the significant gains we have made in keeping people safe. We need to restart the economy only when the time is right, when we are certain we can maintain the health and confidence of Canadians. There needs to be coordination based on science, data and expert advice to realize our shared ambition of seeing our country through this.
I’ll also address Canada’s industrial response to the COVID-19 pandemic.
Over the past month, we have put the full weight of the federal government behind a plan to recalibrate industrial policy and supply chains. We have deployed industry and innovation programming, such as the industrial research assistance program, the strategic innovation fund, the innovation superclusters initiative, innovative solutions Canada and many other programs, to rapidly scale up industrial production of masks, ventilators and other urgently needed goods.
Industry has answered our call. Through our online portal, we have heard from nearly 6,000 Canadian companies that have stepped up to offer their capacity and expertise. These firms are now pivoting towards making face shields, gowns and other much-needed goods to help keep front-line health care workers safe.
The mantra is simple: It’s buy, buy, buy and build, build, build to meet the needs of a pandemic on a scale the country hasn’t seen since Canadian industry mobilized to support the greatest generation overseas, and we are now starting to see the results of these partnerships.
Contracts are now in place for more than 30 million medical gowns. Well-known companies such as Bauer, Stanfield’s, Canada Goose and General Motors have begun producing personal protective equipment and we are working on contracts with 14 different companies to deliver millions of face shields.
Companies such as StarFish Medical have teamed up with key partners to produce ventilators using intellectual property first developed right here in Canada. More than a million litres of ethanol will be provided by Canadian distilleries through the hand sanitizers manufacturing exchange. As well, 55 million masks have been ordered, and we are working to step up mask manufacturing domestically so that we can assure Canada’s access to these vital pieces of personal protective equipment.
This shift has allowed us not only to respond to the need for protective equipment but also to keep many Canadians on payroll.
We've contacted every company that put its hand up. We're working with the other levels of government to leverage Canadian industrial expertise.
These partnerships highlight the innovative and collaborative spirit of Canadian industry, and we continue to challenge industry to come up with new and even more innovative solutions.
Throughout this process, companies of all sizes and all types, from every region of the country, have stepped forward with passion and commitment to do everything possible to help us fight the virus and keep Canadians safe.
In addition to working with industry, the government has been supporting Canada’s world-class scientists, medical experts and researchers in fighting COVID-19.
We're investing aggressively to develop a safe and effective vaccine. We want Canadians to have access to the vaccine and to treatments as soon as they're available.
Ultimately, we want to deliver a vaccine and other treatments so Canadians can return to their regular routines. We want to get the economy moving again and to pave the way for a smooth rebound in the aftermath of this pandemic. Whether we're talking about Canadian companies or world-class researchers at our universities, the co-operation has been excellent.
We all just want to get the job done. That is, after all, the Canadian way.
That concludes my remarks. Again, thank you for the opportunity to speak with your committee today. I'll be pleased to answer your questions.
Thank you.